Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
In multiple myeloma, combination chemotherapy with melphalan plus prednisone has been used
since the 1960s and is regarded as the standard of care in elderly patients. We assess
whether the addition of thalidomide to this combination or adapted high-dose chemotherapy,
using a melphalan 100 mg/m2 -based regimen, would improve survival.